CAPRICOR THERAPEUTICS, INC. Proceeds from Long-Term Debt Issued
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-03-29
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2018-06-30 was -$139.14K, a 155.66% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2018-03-31 was $139.14K.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2017 was $500.00K, a 89.47% decline from fiscal 2016.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2016 was $4.75M.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 102 month | Proceeds from Issuance of Long-term Debt 105 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | -$139.14K derived: sum of 3 quarters · filed 2019-03-29 | $0.00 10-K · filed 2019-03-29 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$139.14K derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $250.00K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-06-30 | -$139.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $250.00K derived: sum of 3 quarters · filed 2019-03-29 | $250.00K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-03-31 | $139.14K 10-Q · filed 2018-05-14 | $389.14K derived: sum of 2 quarters · filed 2019-03-29 | $389.14K derived: sum of 3 quarters · filed 2019-03-29 | $639.14K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2017-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $250.00K derived: sum of 2 quarters · filed 2019-03-29 | $500.00K derived: sum of 3 quarters · filed 2019-03-29 | $500.00K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $250.00K derived: sum of 2 quarters · filed 2018-11-14 | $250.00K 10-Q · filed 2018-11-14 | $250.00K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $250.00K 10-Q · filed 2018-08-13 | $250.00K derived: sum of 3 quarters · filed 2018-08-13 | $2.00M derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-05-14 | $1.75M derived: sum of 3 quarters · filed 2018-05-14 | $3.75M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $1.75M derived: sum of 2 quarters · filed 2018-03-22 | $3.75M derived: sum of 3 quarters · filed 2018-03-22 | $4.75M 10-K · filed 2018-03-22 | ||
| 2016-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.75M derived: sum of 2 quarters · filed 2017-11-14 | $4.75M 10-Q · filed 2017-11-14 | $4.75M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $3.00M 10-Q · filed 2017-08-14 | $3.00M derived: sum of 3 quarters · filed 2017-08-14 | $3.00M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $1.00M 10-Q · filed 2017-05-15 | $1.00M derived: sum of 2 quarters · filed 2017-05-15 | $1.00M derived: sum of 3 quarters · filed 2017-05-15 | $1.00M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $0.00 derived: sum of 3 quarters · filed 2016-08-15 | $514.18K derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2016-05-13 | $514.18K derived: sum of 3 quarters · filed 2016-05-13 | $5.20M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $514.18K derived: sum of 2 quarters · filed 2016-03-30 | $5.20M derived: sum of 3 quarters · filed 2016-03-30 | $5.20M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $514.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $5.20M derived: sum of 2 quarters · filed 2015-11-13 | $5.20M 10-Q · filed 2015-11-13 | $5.20M derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $4.69M 10-Q · filed 2015-08-14 | $4.69M derived: sum of 3 quarters · filed 2015-08-14 | $7.75M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $3.07M derived: sum of 3 quarters · filed 2015-03-16 | $3.07M derived: sum of 4 quarters · filed 2015-03-16 | $3.93M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $3.07M derived: sum of 2 quarters · filed 2015-03-16 | $3.07M derived: sum of 3 quarters · filed 2015-03-16 | $3.93M 10-K · filed 2015-03-16 | $3.93M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $3.07M derived: sum of 2 quarters · filed 2014-11-14 | $3.93M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $857.27K 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $857.27K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |